Navigation Links
Launch of BioOptimal™ MF-SL Microfilters for Bioprocessing
Date:7/29/2010

TOKYO, July 29 /PRNewswire/ -- Asahi Kasei Medical Co., Ltd. is pleased to announce the commercial launch on August 1 of BioOptimal™ MF-SL, its new range of microfilters for bioprocessing applications. Designed specifically for use in cell culture clarification applications, BioOptimal™ MF-SL filters enable biopharmaceutical manufacturers to improve the efficiency and effectiveness of their protein harvest step.

Developed using Asahi Kasei's unique technology base in hollow-fiber filtration and polymer science, BioOptimal™ MF-SL filters offer superior filtration performance that results in faster processing times and higher-quality protein streams, even when filtering high-density cell culture solutions. The unique hollow-fiber membrane structure used in BioOptimal™ MF-SL filters enables gentle processing of cells and proteins in tangential flow mode, which reduces the burden on subsequent processing steps, and additionally makes BioOptimal™ MF-SL filters suitable for use in perfusion-based fermentation processes.

The key features of BioOptimal™ MF-SL are as follows:

  1. High throughput and fast processing times.
  2. Excellent filter performance even with high-density cell culture.
  3. High clarity of filtrate, even with highly turbid cell culture.
  4. Availability of various surface area sizes, making for easy scalability.
  5. Chemically stable polysulfone membrane, compatible with industry standard cleaning and sterilization processes.

About Asahi Kasei Medical

As a part of the Asahi Kasei Group's sharpening focus on healthcare-related fields, Asahi Kasei Medical is steadily developing its range of advanced manufacturing solutions for the bioprocess industry. The company is the established global market leader in virus filtration products, with its Planova™ virus removal filters having an unrivalled 20 year history of trusted use in the production of biotherapeutics. An innovative line-up of equipment solutions for bioprocessing—including chromatography equipment, in-line buffer dilution systems, and virus filtration and integrity test skids—are also available from its wholly owned US subsidiary Asahi Kasei Bioprocess, Inc. The launch of BioOptimal™ MF-SL filters marks a notable addition to Asahi Kasei Medical's range of unique products that continue to provide heightened reliability and efficiency in bioprocessing.


'/>"/>
SOURCE Asahi Kasei Medical Co., Ltd., Planova Division
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Winner Medical Launches Its First Online PurCotton(R) Store in China on Taobao.com
2. Boston Scientific Launches Neuroform EZ(TM) Stent System in U.S. and Europe
3. Bioniche Pharma and Synerx Launch Isosulfan Blue Injection 1%
4. Sysmex America to Launch Complete Cell Image Analysis Portfolio at AACC
5. MAQUET Cardiovascular Launches Advanced VASOVIEW Technology for Endoscopic Vessel Harvesting Procedures in Cardiac Surgery
6. Education Tactics for Thought Leaders, Physicians, Patients and Payers to Support Successful Oncology Product Launches
7. Mylan Launches the Generic Version of Solodyn®, 45 mg, 90 mg and 135 mg Tablets, Announces Settlement Agreement with Medicis
8. Latina Actress and Author Dayanara Torres Launches Online Asthma Education Resource for Hispanic Community in Partnership with Merck and AAFA
9. Dynatronics Launches E-Commerce Website
10. Concert Medical Launches Conductor™ Family of Interventional Coronary Guidewires
11. In the Face of Pain® Launches New Facebook Community for Pain Management Advocates
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/24/2017)... , March 23, 2017  HealthMine surveys with 9,250 ... revealed that health plan members want help from their ... stay engaged in their health, 2) help closing gaps ... platform for health and 5) relevant, real-time guidance. Meeting ... lowering healthcare costs. A Reason ...
(Date:3/24/2017)... , March 23, 2017  Provectus Biopharmaceuticals, Inc. ... "Company"), a clinical-stage oncology and dermatology biopharmaceutical company, ... Financing Commitment Term Sheet (the "Definitive Financing") it ... of the Company,s stockholders, who are referred to ... a Form 8-K filed with the Securities and ...
(Date:3/24/2017)... 24, 2017 The Board of Directors of ... Report 2016 including the complete 2016 Annual Accounts with notes. ... Nordic Nanovector,s website in the section Investor Relations/Reports and presentations/Annual ... ... Kvåle, Chief Financial Officer Cell: +47-91-51-95-76 Email: ir@nordicnanovector.com ...
Breaking Medicine Technology:
(Date:3/24/2017)... ... March 24, 2017 , ... ... spark a conversation on the current obstacles facing infection prevention and offer strategies ... deaths caused by these infections. , The print component of “Fighting Infection” ...
(Date:3/24/2017)... ... 2017 , ... Texas Physical Therapy Specialists (TexPTS) is pleased to announce ... The clinic is the group’s 7th location in San Antonio and 23rd in Texas. ... provide care from the clinic, which opened March 22, 2017. , The ...
(Date:3/24/2017)... ... 2017 , ... As the standards bearer of advanced cancer ... positions them as the go-to thought leader in all matters concerning oncology nursing. ... always-on, always-fresh news, views and advocacy engine, called ONS Voice. , The ONS ...
(Date:3/24/2017)... ... March 24, 2017 , ... Gastro Health (“GH”) ( ... patients for colonoscopy at the HyGIeaCare® Center that is to be located adjacent ... , The HyGIeaCare® Prep, cleared by the U.S. Food and Drug Administration ...
(Date:3/24/2017)... ... , ... “Vintage and Harvest A Cultivation of Christian Love” is the creation ... North Carolina with his wife, Anna Marie. He and his wife are the proud ... also the author of “Shadow and Substance.” , “Love, the agape kind, is seen ...
Breaking Medicine News(10 mins):